Evidence map›Paper›PMID 38184208›Full record

ReviewFrontiers in neuroendocrinology2024

The role of neurosteroids in posttraumatic stress disorder and alcohol use disorder: A review of 10 years of clinical literature and treatment implications.

MacKenzie R Peltier, Terril L Verplaetse, Margaret Altemus, Yasmin Zakiniaeiz, Elizabeth A Ralevski, Yann S Mineur, Ralitza Gueorguieva, Marina R Picciotto, Kelly P Cosgrove, Ismene Petrakis and 1 more

Open access · greenAbstract readReview
In one paragraph

Review in Frontiers in neuroendocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational
  2. Drug Therapy.Advances in experimental medicine and biology · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

MacKenzie R PeltierYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA; VA Connecticut Healthcare System, Mental Health Service, West Haven, CT 06516, USA; National Center for PTSD, Clinical Neuroscience Division, West Haven, CT 06516, USA. Electronic address: mackenzie.peltier@yale.edu.
Terril L VerplaetseYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA.
Margaret AltemusYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA; VA Connecticut Healthcare System, Mental Health Service, West Haven, CT 06516, USA.
Yasmin ZakiniaeizYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA.
Elizabeth A RalevskiYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA; VA Connecticut Healthcare System, Mental Health Service, West Haven, CT 06516, USA.
Yann S MineurYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA.
Ralitza GueorguievaYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA; Department of Biostatistics, School of Public Health, Yale University, New Haven, CT, USA.
Marina R PicciottoYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA.
Kelly P CosgroveYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA; National Center for PTSD, Clinical Neuroscience Division, West Haven, CT 06516, USA; Department of Radiology and Biomedical Imaging, School of Medicine, Yale University, New Haven, CT, USA.
Ismene PetrakisYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA; VA Connecticut Healthcare System, Mental Health Service, West Haven, CT 06516, USA; National Center for PTSD, Clinical Neuroscience Division, West Haven, CT 06516, USA.
Sherry A McKeeYale School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA.
Yale University · US

Funding

Yale-SCORE Resource Support CoreU54AA027989 · NIAAA · YALE UNIVERSITY · PI Sherry Ann McKee · 2020 to 2026
$13.0M
Cholinergic Contribution to Circuits Underlying DepressionR01MH077681 · NIMH · YALE UNIVERSITY · PI MINEUR, YANN SEBASTIEN, PICCIOTTO, MARINA R · 2006 to 2025
$7.0M
Imaging Microglial Activation in PTSD with PETR01MH110674 · NIMH · YALE UNIVERSITY · PI COSGROVE, KELLY P., PIETRZAK, ROBERT H · 2017 to 2020
$3.1M
Anatomical Basis for Nicotine AddictionR37DA014241 · NIDA · YALE UNIVERSITY · PI Marina R Picciotto · 2020 to 2026
$2.7M
Phase 2 study examining efficacy and mechanisms of combining varenicline and guanfacine for smoking cessation in women and menR01DA047986 · NIDA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2020 to 2022
$2.3M
Sex-Appropriate Treatment Development for Alcohol Use DisordersP01AA027473 · NIAAA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2018 to 2019
$1.0M
Behavioral and Neurochemical Mechanisms Underlying Stress-Precipitated DrinkingK01AA025670 · NIAAA · YALE UNIVERSITY · PI VERPLAETSE, TERRIL L · 2018 to 2023
$882k
Sex Differences in Alcohol Use Disorder Neurodegeneration using Multimodal PET and DTI NeuroimagingK01AA029706 · NIAAA · YALE UNIVERSITY · PI Yasmin Zakiniaeiz · 2022 to 2026
$881k
Effect of allopregnanolone on stress-induced cravingR21AA024917 · NIAAA · YALE UNIVERSITY · PI RALEVSKI, ELIZABETH · 2017 to 2019
$344k
Does endotoxin administration increase alcohol consumption in individuals with AUD?R03AA028361 · NIAAA · YALE UNIVERSITY · PI VERPLAETSE, TERRIL L · 2021 to 2022
$168k
Optimal Treatment of Veterans with PTSD and Comorbid Opiate Use Disorder (OUD)I01CX001517 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI PETRAKIS, ISMENE L. · 2018 to 2022
–
CSRD VA I01 CX001517NIAAA NIH HHS K01 AA025670NIAAA NIH HHS K01 AA029706NIAAA NIH HHS P01 AA027473NIAAA NIH HHS R03 AA028361NIAAA NIH HHS R21 AA024917NIAAA NIH HHS U54 AA027989NIDA NIH HHS R01 DA047986NIDA NIH HHS R37 DA014241NIMH NIH HHS R01 MH077681NIMH NIH HHS R01 MH110674
6 · The paper itself

Abstract

Rates of alcohol use disorder (AUD) are increasing in men and women and there are high rates of concurrent posttraumatic stress disorder (PTSD) and AUD. AUD and PTSD synergistically increase symptomatology and negatively affect treatment outcomes; however, there are very limited pharmacological treatments for PTSD/AUD. Neurosteroids have been implicated in the underlying neurobiological mechanisms of both PTSD and AUD and may be a target for treatment development. This review details the past ten years of research on pregnenolone, progesterone, allopregnanolone, pregnanolone, estradiol, testosterone and dehydroepiandrosterone/dehydroepiandrosterone-sulfate (DHEA/DHEA-S) in the context of PTSD and AUD, including examination of trauma/alcohol-related variables, such as stress-reactivity. Emerging evidence that exogenous pregnenolone, progesterone, and allopregnanolone may be promising, novel interventions is also discussed. Specific emphasis is placed on examining the application of sex as a biological variable in this body of literature, given that women are more susceptible to both PTSD diagnoses and stress-related alcohol consumption.

Indexed as

AlcoholismNeurosteroidsStress Disorders, Post-TraumaticAnimalsFemaleHumansMaleNeurosteroidsAlcohol use disorderNeurosteroidsPosttraumatic stress disorderSex as a biological variable

Identifiers

PMID38184208
PMCPMC11185997
OpenAlexW4390578677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.